维普中文期刊产品整合服务
24篇 您的检索式:作者名="RO KS"
    题名 作者 年代 出处 被引量
1Respiratory cancer risks associated with low-level nickel exposure:an integrated assessment based on animal,epidemiological,and mechanistic data显示文摘Steven KS Adriana RO 2003Regul Toxicol Pharmacol2003,37,:1
2Livestoek waste -to -bioenergy generation opportunities 显示文摘CANTRELL KB DUCEY T RO KS 2008Bioresour Teehnol2008,99,17:1
3Terr year experience withtransvagial vesicovaginal fistula repair using tissue interposition显示文摘Eilber KS Kava ler E Ro driguez LV 2003JUrol2003,169,3:1
4Detectiong of eastern equine encephalomyelitis virus and antibody in wild and domestic birds in Massachusetts显示文摘Hayes RO Daniels JB Anderson KS 1962Am J Epidemiol1962,75,:1
5Effects of x-irradiation on survival and extracellular matrix gene expression of cultured keloid fibroblasts显示文摘Lee KS Jung JB Ro YJ 1994J Dermatol Sci1994,8,1:1
6Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer 显示文摘Han HS RO J Lee KS 2008Breast Cancer Res Treat2008,115,2:1
7A randomized phase Ⅲ trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage Ⅱ/Ⅲ breast cancer显示文摘Lee KS Ro J Nam BH 2008Breast Cancer Res Treat2008,109,3:1
8Phase II parallel group study showing comparable efficacy between premenopausal metastatic breast cancer patients treated with letrozole plus goserelin and postmenopausal patients treated with letrozole alone as first-line hormone therapy显示文摘Park IH Ro J Lee KS 2010J Clin Oncol2010,28,16:1
9A randomized phase -Ⅲ tri- al of doeetaxel/capeeitabine versus doxorubicin/eyclophos- phamide as primary chemotherapy for patients with stage Ⅱ / Ⅲ breast cancer 显示文摘Lee KS Ro J Nam BH 2008Breast Cancer Res Treat2008,109,3:1
10Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane cont- aining regimens for early breast cancer 显示文摘Han HS Ro J Lee KS 2009Breast Cancer Res Treat2009,115,2:1
11Differential influence of dietary soy intake on the risk of breast cancer recurrence related to HER2 status 显示文摘Woo HD Park KS Ro J 2012Nutr Cancer2012,64,2:1
12Phase II trial of preoperative pacli-taxel,gemcitabine,and trastuzumab combination therapy inHER2 positive stage II/III breast cancer:The Korean CancerStudy Group BR 07-01显示文摘Im SA Lee KS Ro J 2012Breast Cancer Res Treat2012,132,:1
13Phase II parallel group study showing comparable efficacy between premenopausal metastatic breast cancer patients treated with letrozole plus goserelin and postmenopausal patients treated with letrozole alone as first - line hormone therapy 显示文摘Park IH Ro J Lee KS 2010J Clin Oncol2010,28,16:1
14A randomized phase-Ⅲ trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage Ⅱ/Ⅲ breast cancer显示文摘Lee KS Ro J Nam BH 2008Breast Cancer Res Treat2008,109,3:1
15Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer显示文摘Park IH Ro J Lee KS 2009Ann Oncol2009,20,1:1
16Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer显示文摘Park IH Ro J Lee KS 2009Ann Oncol2009,20,1:1
17Qualitative analysis of volatile organic compounds on biochar显示文摘Spokas KA Novak JM Stewart CE Cantrell KB Uchimiya M Dusaire MG Ro KS 2011Chemosphere2011,85,:1
18CD40L stabilizes arterial thrombi by a beta-3 intgrin-dependent mechanism显示文摘Andre P Prasad KS Denis CV He M Papalia JM Hynes RO 2002Nat Med2002,8,3:1
19Piperlonguminine from Piper longum with inhibitory effects on alpha-melanocyte-stimulating hormone-induced melanogenesis in melanoma B16 cells显示文摘Min KR Kim KS Ro JS 2004Planta Med2004,70,12:1
20Assessment of herbicide sorption by biochars and organic matter associated with soil and sediment显示文摘Sun K Gao B Ro KS Novak JM Wang ZY Herbert S Xing BS 2012Environmental Pollution2012,163,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费